Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$2.39 USD
+0.09 (3.91%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.40 +0.01 (0.42%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.11 |
EPS Last Quarter | 0.35 |
Last EPS Surprise | 488.89% |
ABR | 1.10 |
Earnings ESP
|
-9.09% |
---|---|
Current Year | -0.39 |
Next Year | -0.46 |
EPS (TTM) | -0.44 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.70M | 3.73M | 14.85M | 10.00M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 4.40M | 4.45M | 17.70M | 12.00M |
Low Estimate | 3.00M | 3.00M | 12.00M | 8.00M |
Year ago Sales | 4.71M | 2.40M | 15.45M | 14.85M |
Year over Year Growth Est. | -21.44% | 55.21% | -3.89% | -32.66% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.11 | -0.11 | -0.39 | -0.46 |
# of Estimates | 2 | 2 | 4 | 2 |
Most Recent Consensus | NA | NA | -0.42 | NA |
High Estimate | -0.10 | -0.10 | -0.30 | -0.46 |
Low Estimate | -0.12 | -0.12 | -0.43 | -0.46 |
Year ago EPS | -0.28 | -0.38 | -0.96 | -0.39 |
Year over Year Growth Est. | 60.71% | 71.05% | 59.38% | -17.31% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.11 | -0.11 | -0.39 | -0.46 |
7 Days Ago | -0.11 | -0.11 | -0.39 | -0.46 |
30 Days Ago | -0.10 | -0.10 | -0.44 | NA |
60 Days Ago | -0.10 | -0.10 | -0.45 | NA |
90 Days Ago | -0.10 | -0.10 | -0.45 | -0.38 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.12 | -0.12 | -0.42 | -0.46 |
Zacks Consensus Estimate | -0.11 | -0.11 | -0.39 | -0.46 |
Earnings ESP | -9.09% | -9.09% | -7.86% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.35 | -0.13 | -0.38 | -0.28 | NA |
Estimate | -0.09 | -0.13 | -0.31 | -0.39 | NA |
Difference | 0.44 | 0.00 | -0.07 | 0.11 | 0.12 |
Surprise | 488.89% | 0.00% | -22.58% | 28.21% | 123.63% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more